Lisa Mclaughlin
About Lisa Mclaughlin
Lisa McLaughlin is a scientist with a Bachelor of Science in Biochemistry from Lebanon Valley College. She has extensive experience in drug metabolism and pharmacokinetics, currently working at Venatorx Pharmaceuticals Inc. and previously at Waters Corporation and Frontage Laboratories, Inc.
Work at Venatorx Pharmaceuticals
Lisa McLaughlin has been employed at Venatorx Pharmaceuticals Inc. as a Scientist since 2014. Her role involves significant contributions to research and development in the pharmaceutical sector, particularly focusing on β-lactamase inhibitors. She has been instrumental in projects related to the discovery and development of innovative drug candidates.
Education and Expertise
Lisa McLaughlin earned a Bachelor of Science degree in Biochemistry from Lebanon Valley College. She possesses expertise in Drug Metabolism and Pharmacokinetics (DMPK) and has extensive knowledge in the bioanalytical markets, which supports her work in pharmaceutical research and development.
Background
Prior to her current position, Lisa McLaughlin worked at Waters Corporation as a Bioanalytical Specialist from 2004 to 2013. During her nine years at Waters Corporation in Milford, Massachusetts, she gained valuable experience in bioanalytical techniques and methodologies that have informed her subsequent roles in the industry.
Achievements
Lisa McLaughlin is a recipient of multiple President's Club Awards, which recognize exceptional performance in her field. These awards highlight her contributions and achievements in the pharmaceutical industry, particularly in her roles related to drug development and research.
Research Contributions
Lisa McLaughlin has authored a publication on the discovery of VNRX-7145, an orally bioavailable β-lactamase inhibitor. She has also contributed to research on VNRX-5236, a broad-spectrum β-lactamase inhibitor, and has been involved in the development of VNRX-7145/VNRX-5236 etzadroxil, a prodrug of a boronic acid-containing β-lactamase inhibitor.